Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 922-933

  Busk, Morten ^a   Munk, Ole Lajord ^a   Jakobsen, Steen ^a   Wang, Tobias ^b   Skals, Marianne ^b   Steiniche, Torben ^a   Horsman, Michael Robert ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROAZOMYCIN ARABINOSIDE; PIMONIDAZOLE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; FEMALE; HYPOXIA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR MODEL;

ANIMALS; ANOXIA; CARCINOMA, SQUAMOUS CELL; FEMALE; GINGIVAL NEOPLASMS; HUMANS; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS; NITROIMIDAZOLES; POSITRON-EMISSION TOMOGRAPHY; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 77956566350     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.503970     Document Type: Article

References (25)

1. Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 2004;381:335-354
2. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxyge nation predicts radiation response in advanced squa-mous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-39
3. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77: 18-24.
4. Sorensen BS, Hao J, Overgaard J, Vorum H, Honore B, Alsner J, et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 2005;76: 187-193
5. Sorensen BS, Alsner J, Overgaard J, Horsman MR. Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. Radiother Oncol 2007;83:362-366
6. Busk M, Horsman MR, Overgaard J. Resolution in PET hypo xia imaging: Voxel size matters. Acta Oncol 2008;47: 1201-1210
7. Christian N, Lee JA, Bol A, De BM, Jordan B, Gregoire V. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. Radiother Oncol 2009;91:101-106
8. Mahy P, De BM, de GT, Cheguillaume A, Gillart J, Haustermans K, et al. Comparative pharmacokinetics, bio-distribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models. Radi-other Oncol 2008;89:353-360
9. Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, et al. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30: 317-326
10. O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, et al. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys 2005;61:1493-1502
11. Casciari JJ, Graham MM, Rasey JS. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonida-zole PET time-activity data. Med Phys 1995;22:1127-1139
12. Wang W, Lee NY, Georgi JC, Narayanan M, Guillem J, Schoder H, et al. Pharmacokinetic analysis of hypoxia (18) F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med 2010;51:37-45.
13. Thorwarth D, Eschmann SM, Paulsen F, Alber M. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 2005;50:2209-2224
14. Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M. Kinetic analysis of dynamic 18F-fluoromisonida-zole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 2005;5:152.
15. Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van Der KA, et al. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 2009;92: 429-436
16. Busk M, Horsman MR, Jakobsen S, Keiding S, van Der Kogel AJ, Bussink J, et al. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: A comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys 2008;70:1202-1212
17. Sokoloff, L. Mapping cerebral functional activity with radioactive deoxyglucose. Trends Neurosci 1978;1:75-79
18. Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009;48: 1181-1192
19. Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon J, Houben R, et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 2009; 91:386-392
20. Schinagl DA, Hoffmann AL, Vogel WV, van Dalen JA, Verstappen SM, Oyen WJ, et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Radiother Oncol 2009;91: 95-100.
21. De RD, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, et al. Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): A prospective pilot study. Radiother Oncol 2009;91:415-420
22. Soto DE, Kessler ML, Piert M, Eisbruch A. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol 2008;89: 13-18
23. Lee SW, Nam SY, Im KC, Kim JS, Choi EK, Ahn SD, et al. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 2008;87:211-216
24. Busk M, Horsman MR, Kristjansen PE, van Der Kogel AJ, Bussink J, Overgaard J. Aerobic glycolysis in cancers: Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int J Cancer 2008;122:2726-2734
25. Busk M, Horsman MR, Jakobsen S, Bussink J, van Der KA, Overgaard J. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging 2008;35:2294-2303